tm
Seeing Is Believing
tm
Seeing Is Believing
Merrimack Pharmaceuticals's activity chart (see below) currently has 2 price targets and 2 ratings on display.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 502.2 days.
Most recent stock forecast was given by from MORGAN STANLEY on 19-Oct-2018. First documented stock forecast 19-Dec-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Oct-2018
$4
$-11.13 (-73.56%)
8 years 12 days ago
(19-Oct-2018)
1/1 (100%)
$1.2 (42.86%)
110
Buy Since 27-Oct-2015
$15
$-0.13 (-0.86%)
11 years 4 days ago
(27-Oct-2015)
1/1 (100%)
$-22.4 (-59.89%)
436
Buy Since 11-Aug-2015
$16
$0.87 (5.75%)
11 years 2 months 20 days ago
(11-Aug-2015)
1/1 (100%)
$-23.03 (-59.01%)
506
Buy Since 15-Jun-2015
$16
$0.87 (5.75%)
11 years 4 months 16 days ago
(15-Jun-2015)
1/1 (100%)
$-26.28 (-62.16%)
563
Buy Since 19-Dec-2014
$11
$-4.13 (-27.30%)
11 years 10 months 12 days ago
(19-Dec-2014)
1/1 (100%)
$-31.74 (-74.26%)
896
What is MACK (Merrimack Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on MACK (Merrimack Pharmaceuticals)?
Which analyst has the most public recommendations on MACK (Merrimack Pharmaceuticals)?
Which analyst is the currently most bullish on MACK (Merrimack Pharmaceuticals)?
Which analyst is the currently most reserved on MACK (Merrimack Pharmaceuticals)?
